FMR LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 94 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$357,562
-15.9%
176,139
-4.7%
0.00%
Q2 2023$425,282
-62.4%
184,905
-50.5%
0.00%
Q1 2023$1,131,506
+162.2%
373,434
+101.6%
0.00%
Q4 2022$431,535
+20.9%
185,208
-0.8%
0.00%
Q3 2022$357,000
-19.4%
186,776
+14.4%
0.00%
Q2 2022$443,000
-9.4%
163,307
-0.5%
0.00%
Q1 2022$489,000164,130
+16412900.0%
0.00%
Q2 2021$0
-100.0%
1
-99.7%
0.00%
Q1 2021$1,000
-99.2%
300
-98.4%
0.00%
Q3 2017$119,000
+72.5%
19,2000.0%0.00%
Q2 2017$69,000
+11.3%
19,2000.0%0.00%
Q1 2017$62,000
+31.9%
19,2000.0%0.00%
Q4 2016$47,000
-28.8%
19,2000.0%0.00%
Q3 2016$66,000
-1.5%
19,2000.0%0.00%
Q2 2016$67,000
-15.2%
19,2000.0%0.00%
Q1 2016$79,000
-7.1%
19,2000.0%0.00%
Q4 2015$85,000
+19.7%
19,200
+65.5%
0.00%
Q3 2015$71,00011,6000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q1 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 260,000$866,0000.34%
RTW INVESTMENTS, LP 5,978,355$19,908,0000.31%
GSA CAPITAL PARTNERS LLP 309,839$1,032,0000.17%
QCM Cayman, Ltd. 12,728$42,0000.13%
COWEN AND COMPANY, LLC 486,717$1,621,0000.11%
Hudson Bay Capital Management LP 1,400,000$4,662,0000.06%
Kerrisdale Advisers, LLC 208,150$693,0000.05%
Secure Asset Management, LLC 10,000$33,0000.02%
PDT Partners, LLC 72,500$241,0000.02%
Point72 Asset Management, L.P. 1,037,700$3,456,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders